
<!-- saved from url=(0162)http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm -->
<ion-view title="Home" id="page1">
  <ion-content padding="true" class="has-header"><html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

<meta name="ProgId" content="Word.Document">
<meta name="Generator" content="Microsoft Word 12">
<meta name="Originator" content="Microsoft Word 12">
<link rel="File-List" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus_files/filelist.xml">
<link rel="Edit-Time-Data" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>dell</o:Author>
  <o:LastAuthor>dell</o:LastAuthor>
  <o:Revision>1</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2016-09-08T02:44:00Z</o:Created>
  <o:LastSaved>2016-09-08T02:45:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1049</o:Words>
  <o:Characters>5983</o:Characters>
  <o:Company>Grizli777</o:Company>
  <o:Lines>49</o:Lines>
  <o:Paragraphs>14</o:Paragraphs>
  <o:CharactersWithSpaces>7018</o:CharactersWithSpaces>
  <o:Version>12.00</o:Version>
 </o:DocumentProperties>
</xml><![endif]-->
<link rel="themeData" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus_files/themedata.thmx">
<link rel="colorSchemeMapping" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="0" Name="footnote text"/>
  <w:LsdException Locked="false" Priority="0" Name="header"/>
  <w:LsdException Locked="false" Priority="0" Name="footer"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1107304683 0 0 159 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627400839 -2147483648 8 0 66047 0;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750139 0 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:3.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-unhide:no;
	mso-style-link:"Footnote Text Char";
	margin-top:3.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-unhide:no;
	mso-style-link:"Header Char";
	margin-top:3.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 216.0pt right 432.0pt;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-unhide:no;
	mso-style-link:"Footer Char";
	margin-top:3.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 216.0pt right 432.0pt;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	vertical-align:super;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:3.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:3.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Header;
	mso-ansi-font-size:13pt;
	mso-bidi-font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Footer;
	mso-ansi-font-size:13pt;
	mso-bidi-font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Footnote Text";
	mso-ansi-font-size:13pt;
	mso-bidi-font-size:13pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:13pt;
	line-height:115%;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") fcs;
	mso-endnote-separator:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") es;
	mso-endnote-continuation-separator:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ecs;
	mso-footnote-position:beneath-text;
	mso-footnote-numbering-restart:each-section;}
@page Section1
	{size:21.0cm 841.95pt;
	margin:72.0pt 42.55pt 72.0pt 42.55pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-even-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") eh1;
	mso-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") h1;
	mso-even-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ef1;
	mso-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") f1;
	mso-first-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ff1;
	mso-paper-source:0;}
div.Section1
	{page:Section1;
	mso-footnote-position:beneath-text;
	mso-footnote-numbering-restart:each-section;}
@page Section2
	{size:21.0cm 841.95pt;
	margin:72.0pt 42.55pt 72.0pt 42.55pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-even-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") eh1;
	mso-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") h1;
	mso-even-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ef1;
	mso-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") f1;
	mso-first-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ff1;
	mso-paper-source:0;}
div.Section2
	{page:Section2;
	mso-footnote-position:beneath-text;}
@page Section3
	{size:21.0cm 841.95pt;
	margin:72.0pt 42.55pt 72.0pt 42.55pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-columns:2 even 36.0pt;
	mso-even-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") eh1;
	mso-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") h1;
	mso-even-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ef1;
	mso-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") f1;
	mso-first-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ff1;
	mso-paper-source:0;}
div.Section3
	{page:Section3;
	mso-footnote-position:beneath-text;
	mso-footnote-numbering-restart:each-section;}
@page Section4
	{size:21.0cm 841.95pt;
	margin:72.0pt 42.55pt 72.0pt 42.55pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-even-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") eh1;
	mso-header:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") h1;
	mso-even-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ef1;
	mso-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") f1;
	mso-first-footer:url("Vaccine%20Human%20Papilloma%20Virus_files/header.htm") ff1;
	mso-paper-source:0;}
div.Section4
	{page:Section4;
	mso-footnote-position:beneath-text;}
 /* List Definitions */
 @list l0
	{mso-list-id:165826738;
	mso-list-type:hybrid;
	mso-list-template-ids:337138568 -1151184166 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ansi-font-size:8.0pt;
	font-family:Symbol;}
@list l1
	{mso-list-id:210119890;
	mso-list-type:hybrid;
	mso-list-template-ids:1073409164 -1151184166 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ansi-font-size:8.0pt;
	font-family:Symbol;}
@list l2
	{mso-list-id:798838257;
	mso-list-type:hybrid;
	mso-list-template-ids:-1357329860 -1151184166 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ansi-font-size:8.0pt;
	font-family:Symbol;}
@list l3
	{mso-list-id:859976090;
	mso-list-type:hybrid;
	mso-list-template-ids:1011267346 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l3:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l4
	{mso-list-id:1137915680;
	mso-list-type:hybrid;
	mso-list-template-ids:-67183892 -1151184166 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ansi-font-size:8.0pt;
	font-family:Symbol;}
@list l5
	{mso-list-id:1229657674;
	mso-list-type:hybrid;
	mso-list-template-ids:-2142720204 -1151184166 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ansi-font-size:8.0pt;
	font-family:Symbol;}
@list l6
	{mso-list-id:1419905886;
	mso-list-type:hybrid;
	mso-list-template-ids:1933243546 32788542 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l6:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l7
	{mso-list-id:1470780990;
	mso-list-type:hybrid;
	mso-list-template-ids:-1269291222 1161974188 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l7:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l8
	{mso-list-id:1504390692;
	mso-list-type:hybrid;
	mso-list-template-ids:-1447680556 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l8:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l9
	{mso-list-id:1931155471;
	mso-list-type:hybrid;
	mso-list-template-ids:993062506 -1151184166 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ansi-font-size:8.0pt;
	font-family:Symbol;}
@list l10
	{mso-list-id:2123724414;
	mso-list-type:hybrid;
	mso-list-template-ids:13516200 -1151184166 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ansi-font-size:8.0pt;
	font-family:Symbol;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin-top:0cm;
	mso-para-margin-right:0cm;
	mso-para-margin-bottom:13pt;
	mso-para-margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
<style>
body{
-webkit-touch-callout: none;
}
</style><script async="" src="sany6/58_files/jquery.min.js.download"></script>
</head>

<body lang="EN-US" link="blue" vlink="purple">

<div class="Section1">

<p class="MsoNormal" style="text-align:justify"><b style="mso-bidi-font-weight:
normal"><span style="font-size:12.0pt">Vaccine Human Papilloma Virus<o:p></o:p></span></b></p>

<p class="MsoNormal" style="text-align:justify">Nguyễn Đăng
Phước Hiền <a style="mso-footnote-id:ftn1" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftn1" name="_ftnref1" title=""><span class="MsoFootnoteReference"><span style="mso-special-character:footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:13pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA">[1]</span></span><!--[endif]--></span></span></a>, Nguyễn
Vũ Hà Phúc <a style="mso-footnote-id:ftn2" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftn2" name="_ftnref2" title=""><span class="MsoFootnoteReference"><span style="mso-special-character:
footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:13pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:
&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA">[2]</span></span><!--[endif]--></span></span></a>, Lê
Hồng Cẩm<span class="MsoFootnoteReference"> <a style="mso-footnote-id:
ftn3" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftn3" name="_ftnref3" title=""><span style="mso-special-character:
footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:13pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:
&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA">[3]</span></span><!--[endif]--></span></a></span></p>

<p class="MsoNormal" style="text-align:justify"><span style="font-size:8.0pt">©
Bộ môn Phụ Sản, Khoa Y, Đại học Y
Dược TP. Hồ Chí Minh.</span></p>

</div>

<span style="font-size:13pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:
&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA"><br clear="all" style="page-break-before:auto;
mso-break-type:section-break">
</span>

<div class="Section2">

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:6.0pt 6.0pt 6.0pt 6.0pt;
background:#DAEEF3">

<p class="MsoNormal" style="margin-bottom:6.0pt;text-align:justify;background:
#DAEEF3;border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;
mso-padding-alt:6.0pt 6.0pt 6.0pt 6.0pt">Mục tiêu bài giảng</p>

<p class="MsoNormal" style="text-align:justify;background:white;mso-shading:transparent;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
6.0pt 6.0pt 6.0pt 6.0pt">Sau khi học xong, sinh viên có khả năng:</p>

<p class="MsoNormal" style="margin-left:18.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l7 level1 lfo2;background:white;mso-shading:transparent;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
6.0pt 6.0pt 6.0pt 6.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">1.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]-->Trình
bày cơ chế của vaccine HPV</p>

<p class="MsoNormal" style="margin-left:18.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l7 level1 lfo2;background:white;mso-shading:transparent;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
6.0pt 6.0pt 6.0pt 6.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">2.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]-->Trình
bày các loại vaccine HPV hiện có</p>

<p class="MsoNormal" style="margin-left:18.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l7 level1 lfo2;background:white;mso-shading:transparent;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
6.0pt 6.0pt 6.0pt 6.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">3.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]-->Chỉ
định và cách tiêm phòng vaccine HPV</p>

</div>

</div>

<b style="mso-bidi-font-weight:normal"><span style="font-size:13pt;
font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA"><br clear="all" style="page-break-before:auto;mso-break-type:section-break">
</span></b>

<div class="Section3">

<p class="MsoNormal" style="margin-top:6.0pt;text-align:justify"><b style="mso-bidi-font-weight:normal">VACCINE HUMAN PAPILLOMA VIRUS<o:p></o:p></b></p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51">

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Vaccine phòng HPV
hoạt động trên cơ chế kích hoạt miễn
dịch tế bào sản xuất kháng thể chuyên biệt
type với protein capsid L1 của HPV (tổng hợp bằng
công nghệ VLP).</p>

</div>

<p class="MsoNormal" style="text-align:justify">Capsid của HPV tạo
thành từ các capsome gồm 5 mảnh hình sao protein L1, và khung
nâng đỡ là các protein L2.</p>

<p class="MsoNormal" style="text-align:justify">Kháng nguyên được
chọn để sản xuất vaccine phòng HPV là protein L1
của capsid. Protein L2 là thành phần thứ yếu của
capsid nên không được chọn để chế
tạo vaccine. </p>

<p class="MsoNormal" style="text-align:justify">Vaccine phòng HPV không sử
dụng virus sống, mà chỉ dùng capsid. Hoàn toàn không sử
dụng HPV trong quá trình sản xuất vaccine (noninfectious <u>v</u>irus-<u>l</u>ike
<u>p</u>articles).</p>

<p class="MsoNormal" style="text-align:justify">Genome của HPV
được trích xuất. Đoạn gene mã hóa L1
được đưa vào genome của tế bào eukaryote
(thường là nấm). Vị trí đưa vào là cạnh
đoạn gene khơi mào tiến trình giải mã tổng
hợp protein (Open Reading Frame) (ORF), buộc tế bào eukaryote
sản xuất các monomer của protein L1. Các monomere này
được tổ hợp thành pentamere và cuối cùng là
một capsid không có L2 và không có lõi DNA. Thành phẩm
được dùng làm vaccine phòng HPV.</p>

<p class="MsoNormal" align="center" style="margin-top:12.0pt;text-align:center"><span style="mso-no-proof:yes"><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_149" o:spid="_x0000_i1029" type="#_x0000_t75"
 alt="http://www.esciencecentral.org/ebooks/advances-in-protein-chemistry/images/APC_ProteinsAndPeptides-g002.gif"
 style='width:170.25pt;height:158.25pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="Vaccine%20Human%20Papilloma%20Virus_files/image001.gif"
  o:title="APC_ProteinsAndPeptides-g002"/>
</v:shape><![endif]--><!--[if !vml]--><img width="227" height="211" src="sany6/58_files/image002.jpg" alt="http://www.esciencecentral.org/ebooks/advances-in-protein-chemistry/images/APC_ProteinsAndPeptides-g002.gif" v:shapes="Picture_x0020_149"><!--[endif]--></span></p>

<p class="MsoNormal" style="margin-bottom:12.0pt;text-align:justify"><b style="mso-bidi-font-weight:normal"><span style="font-size:8.0pt;color:#984806;
mso-themecolor:accent6;mso-themeshade:128">Hình 1: </span></b><span style="font-size:8.0pt">Qui trình tổng hợp noninfectious virus-like
particles phòng HPV<o:p></o:p></span></p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51">

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Hiện nay lưu hành
nhiều loại vaccine thương mại là</p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l10 level1 lfo3;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51;border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Các vaccine nhị giá (HPV2) với các
kháng nguyên L1 capsid của HPV type 16 và 18.</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l10 level1 lfo3;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51;border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Các vaccine tứ giá (HPV4) với các
kháng nguyên L1 capsid của HPV type 6, 11, 16 và 18.</p>

</div>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l10 level1 lfo3"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Các vaccine đa giá khác (9 type) vẫn
chưa được phổ biến do chưa có
đủ dữ liệu về hiệu quả và an toàn.</p>

<p class="MsoNormal" style="text-align:justify">Sau khi được tiêm
vaccine, VLP được nhận diện bởi các tế
bào B, và với sự hỗ trợ của các tế bào T,
sẽ kích hoạt các tương bào sản xuất IgG
chuyên biệt cho VLP được đưa vào.</p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51">

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Ký ức miễn
dịch tạo bởi con đường tế bào
B-tế bào T-tương bào là một ký ức miễn
dịch khá bền vững và chuyên biệt. Ký ức
miễn dịch này tạo ra cho các vaccine phòng HPV hai
đặc điểm:</p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l8 level1 lfo4;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">1.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]-->Miễn
dịch dài hạn</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l8 level1 lfo4;background:#DAEEF3;
mso-background-themecolor:accent5;mso-background-themetint:51;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">2.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]-->Chuyên biệt cho type HPV. Vaccine HPV không
tạo ra hiệu quả bảo vệ chéo giữa các type HPV
khác nhau.</p>

</div>

<p class="MsoNormal" style="margin-top:12.0pt;text-align:justify"><span style="mso-no-proof:yes"><!--[if gte vml 1]><v:shape id="Picture_x0020_147"
 o:spid="_x0000_i1028" type="#_x0000_t75" alt="http://image.slidesharecdn.com/hpv-140429220647-phpapp02/95/human-papilloma-virus-cervical-cancer-and-vaccines-50-638.jpg?cb=1398809312"
 style='width:236.25pt;height:139.5pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="Vaccine%20Human%20Papilloma%20Virus_files/image003.jpg"
  o:title="human-papilloma-virus-cervical-cancer-and-vaccines-50-638"
  croptop="8110f" cropbottom="5909f"/>
</v:shape><![endif]--><!--[if !vml]--><img width="315" height="186" src="sany6/58_files/image004.jpg" alt="http://image.slidesharecdn.com/hpv-140429220647-phpapp02/95/human-papilloma-virus-cervical-cancer-and-vaccines-50-638.jpg?cb=1398809312" v:shapes="Picture_x0020_147"><!--[endif]--></span></p>

<p class="MsoNormal" style="text-align:justify"><b style="mso-bidi-font-weight:
normal"><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;;
color:#984806;mso-themecolor:accent6;mso-themeshade:128">Hình 2:</span></b><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;;color:#984806;
mso-themecolor:accent6;mso-themeshade:128"> </span><span style="font-size:8.0pt;
font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;">Con đường tế
bào B-tế bào T-tương bào sản xuất IgG chống
protein capsid VLP<o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;
margin-left:0cm;text-align:justify"><span style="font-size:8.0pt;font-family:
&quot;Calibri Light&quot;,&quot;sans-serif&quot;">IgG kháng VLP của HPV được
tạo ra từ con đường B-T-tương bào
cổ điển, đảm bảo một miễn
dịch chuyên biệt theo type và dài hạn.<o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify">Các vaccine ngăn chặn
trực tiếp lên HPV cũng như các thuốc
điều trị ung thư trúng đích đang
được nghiên cứu, và tỏ ra có nhiều hứa
hẹn.</p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51">

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Vaccine HPV giúp ngăn
ngừa nhiễm qua tiếp xúc đường sinh dục
và ngoài sinh dục các type HPV chuyên biệt.</p>

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Có khác biệt
giữa các vaccine nhị giá và tứ giá.</p>

</div>

<p class="MsoNormal" style="text-align:justify">Các vaccine tứ giá (HPV4) nhằm
vào các type 6, 11, 16, 18 của HPV, có một khả năng
bảo vệ rộng trên âm hộ, âm đạo và các
tổn thương condyloma accuminatum. Vaccine tứ giá giúp
ngăn ngừa 91% nhiễm mới và ngăn ngừa 100%
nhiễm dai dẳng.</p>

<p class="MsoNormal" style="text-align:justify">Hiệu quả của
vaccine nhị giá (HPV2) chỉ khu trú trên các type 16 và 18 của
HPV. Vaccine nhị giá không được thiết kế
nhằm vào bảo vệ các tân sinh trong biểu mô ở âm
hộ (VIN), hay âm đạo (VaIN) cũng như condyloma
accuminatum. </p>

<p class="MsoNormal" style="margin-top:12.0pt;text-align:justify"><span style="mso-no-proof:yes"><!--[if gte vml 1]><v:shape id="Picture_x0020_1037"
 o:spid="_x0000_i1027" type="#_x0000_t75" alt="http://www.cdc.gov/features/preventhpv/preventhpv_c600px.gif"
 style='width:237pt;height:99.75pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="Vaccine%20Human%20Papilloma%20Virus_files/image005.gif"
  o:title="preventhpv_c600px"/>
</v:shape><![endif]--><!--[if !vml]--><img width="316" height="133" src="sany6/58_files/image006.jpg" alt="http://www.cdc.gov/features/preventhpv/preventhpv_c600px.gif" v:shapes="Picture_x0020_1037"><!--[endif]--></span></p>

<p class="MsoNormal" style="text-align:justify"><b style="mso-bidi-font-weight:
normal"><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;;
color:#984806;mso-themecolor:accent6;mso-themeshade:128">Hình 3:</span></b><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;;color:#984806;
mso-themecolor:accent6;mso-themeshade:128"> </span><span style="font-size:8.0pt;
font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;">Phổ bảo vệ
của vaccine HPV nhị giá, tứ giá và 9 type HPV<o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify"><span style="mso-no-proof:yes"><!--[if gte vml 1]><v:shape
 id="Picture_x0020_145" o:spid="_x0000_i1026" type="#_x0000_t75" alt="http://image.slidesharecdn.com/latestupdateoncervicalcancerhpvvaccine-2013-130904054814-/95/latest-update-on-cervical-cancer-hpv-vaccine-2013-19-638.jpg?cb=1381137325"
 style='width:237pt;height:177.75pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="Vaccine%20Human%20Papilloma%20Virus_files/image007.jpg"
  o:title="latest-update-on-cervical-cancer-hpv-vaccine-2013-19-638"/>
</v:shape><![endif]--><!--[if !vml]--><img width="316" height="237" src="sany6/58_files/image008.jpg" alt="http://image.slidesharecdn.com/latestupdateoncervicalcancerhpvvaccine-2013-130904054814-/95/latest-update-on-cervical-cancer-hpv-vaccine-2013-19-638.jpg?cb=1381137325" v:shapes="Picture_x0020_145"><!--[endif]--></span></p>

<p class="MsoNormal" style="text-align:justify"><b style="mso-bidi-font-weight:
normal"><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;;
color:#984806;mso-themecolor:accent6;mso-themeshade:128">Hình 4:</span></b><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;;color:#984806;
mso-themecolor:accent6;mso-themeshade:128"> </span><span style="font-size:8.0pt;
font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;">So sánh vaccine HPV nhị giá và
tứ giá<o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:0cm;margin-right:0cm;margin-bottom:12.0pt;
margin-left:0cm;text-align:justify"><span style="font-size:8.0pt;font-family:
&quot;Calibri Light&quot;,&quot;sans-serif&quot;">Các tác động sau của vaccine
nhị giá chưa được chứng minh là khả
năng bảo vệ khỏi CIN 2 gây bởi HPV type 18,
khả năng bảo vệ khỏi CIN 3 gây bởi type 16
và 18, khả năng bảo vệ khỏi tân sinh trong biêu mô
âm đạo và condyloma accuminata, không có khả năng
bảo vệ chéo về thương tổn và thiếu
dữ liệu về khả năng bảo vệ dài
hạn.<o:p></o:p></span></p>

<p class="MsoNormal" style="margin-top:6.0pt;text-align:justify"><b style="mso-bidi-font-weight:normal">SỬ DỤNG VACCINE HPV THEO ACIP </b><a style="mso-footnote-id:ftn4" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftn4" name="_ftnref4" title=""><span class="MsoFootnoteReference"><span style="mso-special-character:footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:13pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA">[4]</span></span><!--[endif]--></span></span></a><b style="mso-bidi-font-weight:normal"><o:p></o:p></b></p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#002060">

<p class="MsoNormal" style="text-align:justify;background:#002060;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">ACIP
đề nghị các đối tượng cần
được tiêm phòng thường qui HPV vaccine như sau:</p>

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><i style="mso-bidi-font-style:
normal">Tiêm phòng thường qui <o:p></o:p></i></p>

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><span style="font-size:
8.0pt">(mức khuyến cáo: mạnh, mức chứng cứ:
trung bình)<o:p></o:p></span></p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l9 level1 lfo5;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Trẻ gái 11-12 tuổi: HPV4 hay HPV2.
Có thể bắt đầu từ năm 9 tuổi</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l9 level1 lfo5;background:#DAEEF3;
mso-background-themecolor:accent5;mso-background-themetint:51;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Trẻ trai 11-12 tuổi: HPV4</p>

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><i style="mso-bidi-font-style:
normal">Nếu chưa được tiêm phòng thường
qui<o:p></o:p></i></p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l2 level1 lfo6;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Phụ nữ 13-26 tuổi</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l2 level1 lfo6;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Nam giới 13-21 tuổi. Có thể
đến 26 tuổi</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l2 level1 lfo6;background:#DAEEF3;
mso-background-themecolor:accent5;mso-background-themetint:51;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Nam giới có quan hệ tình dục
đồng tính nên tiêm đến 26 tuổi, nếu chưa
được tiêm trước đó</p>

</div>

<p class="MsoNormal" style="text-align:justify">Theo ACIP, không cần
thiết phải thực hiện các tầm soát yếu
tố nguy cơ như PAP test, HPV DNA hay kháng thể HPV
trước khi tiêm.</p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#E36C0A;mso-background-themecolor:accent6;mso-background-themeshade:
191">

<p class="MsoNormal" style="text-align:justify;background:#E36C0A;mso-background-themecolor:
accent6;mso-background-themeshade:191;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><span style="color:white;
mso-themecolor:background1">Các đối tượng không
thường qui là trên phụ nữ đã phơi nhiễm
với HPV<o:p></o:p></span></p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l1 level1 lfo10;
background:#FDE9D9;mso-background-themecolor:accent6;mso-background-themetint:
51;border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Vaccine HPV có thể ít hiệu quả
trên những phụ nữ đã phơi nhiễm với
virus HPV. </p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l1 level1 lfo10;
background:#FDE9D9;mso-background-themecolor:accent6;mso-background-themetint:
51;border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Những phụ nữ đã quan
hệ tình dục, tiền căn tế bào học cổ
tử cung bất thường hay mụn cóc vẫn có
thể có lợi từ việc tiêm phòng HPV.</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l1 level1 lfo10;background:
#FDE9D9;mso-background-themecolor:accent6;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Những phụ nữ đã
nhiễm virus HPV trước đó nếu chích vaccine HPV có
thể tạo kháng thể bảo vệ đối với
những type HPV mà họ chưa nhiễm.</p>

</div>

<p class="MsoNormal" style="margin-top:12.0pt;text-align:justify"><span style="mso-no-proof:yes"><!--[if gte vml 1]><v:shape id="Picture_x0020_1036"
 o:spid="_x0000_i1025" type="#_x0000_t75" alt="http://www.cityofchicago.org/content/dam/city/depts/cdph/clinical_care_and_more/ACIPinfographic.jpg"
 style='width:237pt;height:118.5pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="Vaccine%20Human%20Papilloma%20Virus_files/image009.jpg"
  o:title="ACIPinfographic"/>
</v:shape><![endif]--><!--[if !vml]--><img width="316" height="158" src="sany6/58_files/image010.jpg" alt="http://www.cityofchicago.org/content/dam/city/depts/cdph/clinical_care_and_more/ACIPinfographic.jpg" v:shapes="Picture_x0020_1036"><!--[endif]--></span></p>

<p class="MsoNormal" style="margin-bottom:12.0pt;text-align:justify"><b style="mso-bidi-font-weight:normal"><span style="font-size:8.0pt;font-family:
&quot;Calibri Light&quot;,&quot;sans-serif&quot;;color:#984806;mso-themecolor:accent6;mso-themeshade:
128">Hình 5:</span></b><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;;
color:#984806;mso-themecolor:accent6;mso-themeshade:128"> </span><span style="font-size:8.0pt;font-family:&quot;Calibri Light&quot;,&quot;sans-serif&quot;">Đối
tượng tiêm phòng thường qui HPV<o:p></o:p></span></p>

<p class="MsoNormal" style="text-align:justify">Cả hai loại vaccine
đều được tiêm bằng đường tiêm
bắp, vào cơ delta. Lắc kỹ vaccine trước khi
tiêm.</p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51">

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Cả HPV4 và HPV2
đều được tiêm thành 3 mũi. </p>

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Lịch tiêm không khác
thay đổi theo loại vaccine dùng.</p>

</div>

<p class="MsoNormal" style="text-align:justify">Lịch tiêm HPV
được chia thành 3 liều, không lệ thuộc vào
loại vaccine dùng. </p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51">

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l3 level1 lfo7;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">1.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]-->Liều
1: ngày bắt đầu</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l3 level1 lfo7;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">2.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><!--[endif]-->Liều
2: 1-2 tháng sau liều đầu</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l3 level1 lfo7;background:#DAEEF3;
mso-background-themecolor:accent5;mso-background-themetint:51;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="mso-list:Ignore">3.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]-->Liều 3: 6 tháng sau liều đầu</p>

</div>

<p class="MsoNormal" style="text-align:justify">Nếu liều thứ 3<sup>rd</sup>
đến vào tuổi 26 thì người dùng vẫn nên hoàn
tất liệu trình 3 mũi, dù đang ở tuổi 27.</p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#002060">

<p class="MsoNormal" style="text-align:justify;background:#002060;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Phải
tuân thủ lịch tiêm. Không được tiêm sớm
hơn khoảng cách tối thiểu giữa hai mũi tiêm.</p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l0 level1 lfo8;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Khoảng cách tối thiểu
phải tuân thủ giữa liều 1<sup>st</sup> và liều 2<sup>nd</sup>
là bốn tuần (một tháng).</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l0 level1 lfo8;background:
#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Khoảng cách tối thiểu
phải tuân thủ giữa liều 2<sup>nd</sup> và liều 3<sup>rd</sup>
là mười hai tuần (ba tháng).</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l0 level1 lfo8;background:#DAEEF3;
mso-background-themecolor:accent5;mso-background-themetint:51;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Khoảng cách tối thiểu
phải tuân thủ giữa liều 1<sup>st</sup><span style="mso-spacerun:yes">&nbsp; </span>và liều 3<sup>rd</sup> là hai
mươi bốn tuần (sáu tháng).</p>

<p class="MsoNormal" style="text-align:justify;background:#4F6228;mso-background-themecolor:
accent3;mso-background-themeshade:128;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><span style="color:white;
mso-themecolor:background1">Một số điểm lưu ý trong
lịch tiêm:<o:p></o:p></span></p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l5 level1 lfo9;background:
#EAF1DD;mso-background-themecolor:accent3;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Nếu tiêm thuốc bị gián
đoạn (tiêm trễ hạn), bất chấp loại
vaccine dùng là HPV2 hay HPV4</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l5 level1 lfo9;background:
#EAF1DD;mso-background-themecolor:accent3;mso-background-themetint:51;
border:none;mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:
1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;
mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Không phải lặp lại từ
đầu, mà chỉ tiếp tục liệu trình.</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l5 level1 lfo9;background:#EAF1DD;
mso-background-themecolor:accent3;mso-background-themetint:51;border:none;
mso-border-alt:solid windowtext .5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Nếu mũi 2<sup>nd</sup> bị tiêm
trễ thì phải tiêm mũi thứ 2<sup>nd</sup>, và lưu ý
rằng mũi thứ 3<sup>rd</sup> phải cách mũi thứ
2<sup>nd</sup> ít nhất là mười hai tuần (ba tháng).</p>

</div>

<p class="MsoNormal" style="text-align:justify">Một số lưu ý
khác:</p>

<p class="MsoListParagraphCxSpFirst" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l4 level1 lfo11"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Ở bé trai, chỉ được
phép dùng HPV4. HPV2 không được dán nhãn (labelled) cho bé
trai.</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l4 level1 lfo11"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Nên tiêm với cùng một loại
vaccine. Trong trường hợp bất khả kháng, vẫn
phải tiếp tục tiêm vaccine thay cho loại đã dùng
trước đó.</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l4 level1 lfo11"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Có thể tiêm vaccine cùng lúc với các
vaccine khác như: uốn ván, bạch hầu, ho gà, vaccine màng
não tứ giá. Chỉ cần tuân thủ rằng không
được hòa chung vào một ống tiêm.</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l4 level1 lfo11"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Lưu ý tình trạng ngất (do
phản ứng dây X) có thể xảy ra sau tiêm. Cần theo
dõi sau tiêm 15 phút.</p>

<p class="MsoListParagraphCxSpMiddle" style="margin-left:18.0pt;mso-add-space:
auto;text-align:justify;text-indent:-18.0pt;mso-list:l4 level1 lfo11"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Chống chỉ định của
tiêm phòng HPV là dị ứng với thuốc. HPV4
được sản xuất từ nấm <i style="mso-bidi-font-style:normal">Saccharomyces cerevisiae</i> (men bột
nổi làm bánh). Dị ứng với nấm men là chống
chỉ định của HPV4.</p>

<p class="MsoListParagraphCxSpLast" style="margin-left:18.0pt;mso-add-space:auto;
text-align:justify;text-indent:-18.0pt;mso-list:l4 level1 lfo11"><!--[if !supportLists]--><span style="font-size:8.0pt;mso-bidi-font-size:13pt;font-family:Symbol;mso-fareast-font-family:
Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><!--[endif]-->Không nên tiêm HPV khi đang có một
tình trạng không khỏe. Nếu đến lúc phải tiêm
lặp lại, thì nên tiêm trễ hơn. Tuy nhiên, các tình
trạng bệnh nhẹ như viêm hô hấp trên không
phải là lý do để trì hoãn tiêm.</p>

<p class="MsoNormal" style="margin-top:6.0pt;text-align:justify"><b style="mso-bidi-font-weight:normal">TẦM SOÁT UNG THƯ CỔ
TỬ CUNG SAU TIÊM VACCINE HPV<o:p></o:p></b></p>

<div style="mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:#DAEEF3;mso-background-themecolor:accent5;mso-background-themetint:
51">

<p class="MsoNormal" style="text-align:justify;background:#DAEEF3;mso-background-themecolor:
accent5;mso-background-themetint:51;border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt">Theo khuyến cáo
của ACOG và ASCCP, chương trình tầm soát ung thư
cổ tử cung không thay đổi trên những phụ
nữ đã chích ngừa vaccine HPV.</p>

</div>

</div>

<span style="font-size:13pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:
&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA"><br clear="all" style="page-break-before:auto;
mso-break-type:section-break">
</span>

<div class="Section4">

<p class="MsoNormal" style="margin-top:0cm;text-align:justify"><b style="mso-bidi-font-weight:normal"><u><span style="font-size:6.0pt;color:black;
mso-themecolor:text1"><span style="mso-tab-count:3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><o:p></o:p></span></u></b></p>

<p class="MsoNormal" style="text-align:justify"><b style="mso-bidi-font-weight:
normal"><span style="font-size:8.0pt">TÀI LIỆU ĐỌC THÊM<o:p></o:p></span></b></p>

<p class="MsoNormal" style="margin-left:18.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l6 level1 lfo1"><!--[if !supportLists]--><span style="mso-list:
Ignore">1.<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><!--[endif]--><span style="font-size:8.0pt">ACIP. Human
Papillomavirus Vaccination: Recommendations of the Advisory Committee on
Immunization Practices (ACIP). Aug 2014.</span></p>

</div>

<div style="mso-element:footnote-list"><!--[if !supportFootnotes]--><br clear="all">

<hr align="left" size="1" width="33%">

<!--[endif]-->

<div style="mso-element:footnote" id="ftn1">

<p class="MsoFootnoteText"><a style="mso-footnote-id:ftn1" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftnref1" name="_ftn1" title=""><span class="MsoFootnoteReference"><span style="font-size:
8.0pt"><span style="mso-special-character:footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA">[1]</span></span><!--[endif]--></span></span></span></a><span style="font-size:8.0pt"> Giảng viên, bộ môn Phụ Sản,
Đại học Y Dược TP. Hồ Chí Minh. e-mail: </span><a href="mailto:drhiennguyen1986@gmail.com"><span style="font-size:8.0pt">drhiennguyen1986@gmail.com</span></a><span style="font-size:8.0pt"> <o:p></o:p></span></p>

</div>

<div style="mso-element:footnote" id="ftn2">

<p class="MsoFootnoteText"><a style="mso-footnote-id:ftn2" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftnref2" name="_ftn2" title=""><span class="MsoFootnoteReference"><span style="font-size:
8.0pt"><span style="mso-special-character:footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA">[2]</span></span><!--[endif]--></span></span></span></a><span style="font-size:8.0pt"> Giảng viên, bộ môn Phụ Sản,
Đại học Y Dược TP. Hồ Chí Minh. e-mail: </span><a href="mailto:nvhphuc03@gmail.com"><span style="font-size:8.0pt">nvhphuc03@gmail.com</span></a><span style="font-size:8.0pt"> <o:p></o:p></span></p>

</div>

<div style="mso-element:footnote" id="ftn3">

<p class="MsoFootnoteText"><a style="mso-footnote-id:ftn3" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftnref3" name="_ftn3" title=""><span class="MsoFootnoteReference"><span style="font-size:
8.0pt"><span style="mso-special-character:footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA">[3]</span></span><!--[endif]--></span></span></span></a><span style="font-size:8.0pt"> Giảng viên Bộ môn Phụ Sản,
Đại học Y Dược TP. Hồ Chí Minh. e-mail: </span><a href="mailto:lehongcam61@yahoo.com"><span style="font-size:8.0pt">lehongcam61@yahoo.com</span></a><span style="font-size:8.0pt"> <span style="mso-spacerun:yes">&nbsp;</span></span><span class="MsoFootnoteReference"><span style="mso-spacerun:yes">&nbsp;</span><o:p></o:p></span></p>

</div>

<div style="mso-element:footnote" id="ftn4">

<p class="MsoFootnoteText" style="text-align:justify"><a style="mso-footnote-id:
ftn4" href="http://elearning.yds.edu.vn/file.php/746/T%C3%A2n%20sinh%20trong%20bi%E1%BB%83u%20m%C3%B4%20c%E1%BB%95%20t%E1%BB%AD%20cung/Vaccine%20Human%20Papilloma%20Virus.htm#_ftnref4" name="_ftn4" title=""><span class="MsoFootnoteReference"><span style="font-size:8.0pt"><span style="mso-special-character:footnote"><!--[if !supportFootnotes]--><span class="MsoFootnoteReference"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA">[4]</span></span><!--[endif]--></span></span></span></a><span style="font-size:8.0pt"> CDC's Advisory Committee on Immunization Practices
(ACIP). Human Papillomavirus Vaccination: Recommendations of the ACIP. Aug 2014<o:p></o:p></span></p>

</div>

</div>




</body>
</html>
</ion-content>
</ion-view>